258 related articles for article (PubMed ID: 15347469)
1. [Comparison of the effect of fluoxetine combined with hormone replacement therapy (HRT) and single HRT in treating menopausal depression].
Yu Q; Yin CX; Hui Y; Yu J; He FF; Wei J; Wu YY
Zhonghua Fu Chan Ke Za Zhi; 2004 Jul; 39(7):461-4. PubMed ID: 15347469
[TBL] [Abstract][Full Text] [Related]
2. Menopausal depression: comparison of hormone replacement therapy and hormone replacement therapy plus fluoxetine.
Liu P; He FF; Bai WP; Yu Q; Shi W; Wu YY; He DJ; Xiao JH; Zheng Y; Liao QP
Chin Med J (Engl); 2004 Feb; 117(2):189-94. PubMed ID: 14975200
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of different antidepression therapy in perimenopausal and postmenopausal women with depression].
Lai AL; Zhao YW; Qi HY; Zhang JS; Zhang LS; Weng YQ
Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):169-72. PubMed ID: 17537301
[TBL] [Abstract][Full Text] [Related]
4. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women.
Gambacciani M; Ciaponi M; Cappagli B; Monteleone P; Benussi C; Bevilacqua G; Vacca F; Genazzani AR
Maturitas; 2005 Feb; 50(2):91-7. PubMed ID: 15653005
[TBL] [Abstract][Full Text] [Related]
5. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study.
Chandeying V; Sangthawan M
J Med Assoc Thai; 2007 Sep; 90(9):1720-6. PubMed ID: 17957910
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause.
Woo J; Lau E; Ho SC; Cheng F; Chan C; Chan AS; Haines CJ; Chan TY; Li M; Sham A
Menopause; 2003; 10(4):352-61. PubMed ID: 12851519
[TBL] [Abstract][Full Text] [Related]
7. Mood modifications with raloxifene and continuous combined estrogen plus progestin hormone therapy.
Carranza-Lira S; MacGregor-Gooch AL; Saráchaga-Osterwalder M
Int J Fertil Womens Med; 2004; 49(3):120-2. PubMed ID: 15303313
[TBL] [Abstract][Full Text] [Related]
8. [The effects of hormone replacement therapy in menopause on symptoms of anxiety and depression].
Yazici K; Pata O; Yazici A; Aktaş A; Tot S; Kanik A
Turk Psikiyatri Derg; 2003; 14(2):101-5. PubMed ID: 12844276
[TBL] [Abstract][Full Text] [Related]
9. The role of hormone replacement therapy in endometrial polyp formation.
Oguz S; Sargin A; Kelekci S; Aytan H; Tapisiz OL; Mollamahmutoglu L
Maturitas; 2005 Mar; 50(3):231-6. PubMed ID: 15734604
[TBL] [Abstract][Full Text] [Related]
10. Conjugated estrogen plus medroxyprogesterone does not impair blood rheological properties in hypertensive postmenopausal women.
Sumino H; Ichikawa S; Takahashi T; Sakamoto H; Goto-Onozato K; Koya S; Kanda T; Nara M; Seki K; Murakami M; Kurabayashi M
Maturitas; 2006 Feb; 53(3):306-14. PubMed ID: 16040211
[TBL] [Abstract][Full Text] [Related]
11. Do different delivery systems of hormone therapy have different effects on psychological symptoms in surgically menopausal women? A randomized controlled trial.
Baksu B; Baksu A; Göker N; Citak S
Maturitas; 2009 Feb; 62(2):140-5. PubMed ID: 19179026
[TBL] [Abstract][Full Text] [Related]
12. Effects of postmenopausal hormone replacement therapy on body fat composition.
Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
[TBL] [Abstract][Full Text] [Related]
13. Anticardiolipin antibodies during hormone replacement therapy in healthy postmenopausal women.
Todorova M; Kamenov Z; Baleva M; Christov V; Nicolov K
Maturitas; 2004 Aug; 48(4):393-7. PubMed ID: 15283931
[TBL] [Abstract][Full Text] [Related]
14. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
Savoca S; D'Agosta S; Lombardo G
Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
[TBL] [Abstract][Full Text] [Related]
16. The effects of different hormone replacement therapy regimens on tear function, intraocular pressure and lens opacity.
Uncu G; Avci R; Uncu Y; Kaymaz C; Develioğlu O
Gynecol Endocrinol; 2006 Sep; 22(9):501-5. PubMed ID: 17071534
[TBL] [Abstract][Full Text] [Related]
17. Effects of menopause and hormone therapy on erythrocyte deformability.
Sakashita T; Nobuzane T; Miyoshi H; Fujiwara H; Kudo Y
Menopause; 2009; 16(3):555-8. PubMed ID: 19169165
[TBL] [Abstract][Full Text] [Related]
18. [Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].
Ortiz Núñez DA; Mengchún López G; Hernández Marín I; Mendoza R; Ayala Ruíz AR
Ginecol Obstet Mex; 2004 Jul; 72():349-55. PubMed ID: 15469174
[TBL] [Abstract][Full Text] [Related]
19. Effect of oestrogen replacement therapy on bone mass in post-menopausal Bangladeshi women.
Begum F; Shamsuddin L; Hussain MA; Chowdhury TA; Rahman M; Das TR
Bangladesh Med Res Counc Bull; 2001 Dec; 27(3):103-11. PubMed ID: 12197624
[TBL] [Abstract][Full Text] [Related]
20. Dry eye in post-menopausal women using hormone replacement therapy.
Erdem U; Ozdegirmenci O; Sobaci E; Sobaci G; Göktolga U; Dagli S
Maturitas; 2007 Mar; 56(3):257-62. PubMed ID: 17030104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]